Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rituximab Combined With Cyclosporine Versus Rituximab Alone in Idiopathic Membranous Nephropathy
NCT04743739Phase 3Terminated
- Sponsor
- Peking Union Medical College Hospital
- Start
- Apr 2021
- Primary completion
- Dec 2022
- Modality
- Peptides, Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of cyclosporine in idiopathic membranous nephropathy (IMN), sponsored by Peking Union Medical College Hospital. Started Apr 2021; status: terminated.
02
Drugs
cyclosporine
03
Conditions
idiopathic membranous nephropathy (IMN)
Beyond the preview
Go deeper on NCT04743739.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04743739.